Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 70,571 | 67,437 | 62,353 | 60,525 | 55,293 |
| Cost of Goods | 9,417 | 8,399 | 6,676 | 6,552 | 6,945 |
| Gross Profit | 61,154 | 59,038 | 55,677 | 53,973 | 48,348 |
| Operating Expenses | 126,406 | 112,198 | 107,698 | 132,582 | 138,316 |
| Operating Income | -64,835 | -52,761 | -51,345 | -78,057 | -89,023 |
| Interest Expense | 8,277 | 6,784 | 3,635 | 3,729 | 3,767 |
| Other Income | -482 | -3,739 | 6,191 | -6,801 | 2,905 |
| Pre-tax Income | -73,594 | -63,284 | -48,789 | -88,587 | -89,885 |
| Income Tax | -2,193 | 727 | 3,703 | 361 | -156 |
| Net Income Continuous | -71,401 | -64,011 | -52,492 | -88,948 | -89,729 |
| Net Income | $-71,401 | $-64,011 | $-52,492 | $-88,948 | $-89,729 |
| EPS Basic Total Ops | -0.27 | -0.25 | -0.20 | -0.35 | -0.32 |
| EPS Basic Continuous Ops | -0.27 | -0.25 | -0.20 | -0.35 | -0.32 |
| EPS Diluted Total Ops | -0.27 | -0.25 | -0.20 | -0.35 | -0.32 |
| EPS Diluted Continuous Ops | -0.27 | -0.25 | -0.20 | -0.35 | -0.32 |
| EBITDA(a) | $-61,618 | $-49,673 | $-49,005 | $-76,062 | $-87,253 |